Osimertinib for Japanese patients with T790M‐positive advanced non‐small‐cell lung cancer: A pooled subgroup analysis

Epidermal growth factor receptor (EGFR)‐tyrosine kinase inhibitors (TKIs) are the standard of care for non‐small‐cell lung cancer (NSCLC) patients harboring EGFR mutations. However, almost all patients develop resistance after approximately 1 y of treatment, with >50% of cases due to the T790M se...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Sci
Autors principals: Hirashima, Tomonori, Satouchi, Miyako, Hida, Toyoaki, Nishio, Makoto, Kato, Terufumi, Sakai, Hiroshi, Imamura, Fumio, Kiura, Katsuyuki, Okamoto, Isamu, Kasahara, Kazuo, Uchida, Hirohiko, Vowler, Sarah L., Mitsudomi, Tetsuya
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2019
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6726692/
https://ncbi.nlm.nih.gov/pubmed/31265163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14120
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars